Glutathione S-transferases as emerging therapeutic targets

Bibliography

• BOOTH J, BOYLAND E, SIMS P: An enzyme from rat liver catalyzing conjugations with glutathione. Biochem. I (1961) 79:516–524.
   Google Scholar
• •The first report concerning the discovery of a GST and its ability to catalyse conjugations to glutathione.
   Google Scholar
• BABBITT PC: Reengineering the glutathione 5-transferase scaffold: a rational design strategy pays off. Proc. Natl. Acad. Sci. USA (2000) 97:10298–10300.
   PubMed Web of Science ®Google Scholar
• MANNERVIK B, AWASTHI YC, BOARD PG et al.: Nomenclature for human glutathione transferases. Biochem. 1 (1992) 282:305-306. es"Modem" nomenclature of GSTs based on their genetic characteristics and substrate specificity.
   Google Scholar
• BOARD PG, COGGAN M, CHELVANAYAGAM G et al.: Identification, characterisation, and crystal structure of the Omega class glutathione transferases. j Biol. Chem. (2000) 275:24798–24806.
   PubMed Web of Science ®Google Scholar
• MORGENSTERN R, DEPIERRE JW, JORNVALL H: Microsomal glutathione transferase. Primary structure. I Biol. Chem. (1985) 260:13976–13983.
   Google Scholar
• DIRR H, REINEMERP, HUBER R: X-ray crystal structures of cytosolic glutathione 5-transferases. Implications for protein architecture, substrate recognition and catalytic function. Eur. j Biochem. (1994) 220:645–661.
   Google Scholar
• ARMSTRONG RN: Structure, catalyticmechanism, and evolution of the glutathione transferases. Chem. Res. Toxicol. (1997) 10:2–18.
   PubMed Web of Science ®Google Scholar
• •Excellent review on the catalytic mechanism of GSTs.
   Google Scholar
• ATKINS WM, WANG RW, BIRD AW, NEWTON DJ, LU AY: The catalytic mechanism of glutathione 5-transferase (GST). Spectroscopic determination of the pKa of Tyr-9 in rat alpha 1-1 GST. I Biol. Chem. (1993) 268:19188–19191.
   Google Scholar
• MEYER DJ, GILMORE KS, HARRIS JM,HARTLEY JA, KETTERER B: Chlorambucil-monoglutathionyl conjugate is sequestered by human alpha class glutathione 5-transferases. Br 1. Cancer (1992) 66:433–438.
   Google Scholar
• MEYER DJ, CREASE DJ, KETTERER B: Forward and reverse catalysis and product sequestration by human glutathione 5-transferases in the reaction of GSH with dietary aralkyl isothiocyanates. Biochem. I (1995) 306:565–569.
   Google Scholar
• TOMAREV SI, CHUNG S, PIATIGORSKY J: Glutathione 5-transferase and S-crystallins of cephalopods: evolution from active enzyme to lens-refractive proteins. 1. Ma. Evol. (1995) 41:1048–1056.
   Google Scholar
• DULHUNTY A, GAGE P, CURTIS S, CHELVANAYAGAM G, BOARD P: The glutathione transferase structural family includes a nuclear chloride channel and a ryanodine receptor calcium release channel modulator. J Bid. Chem. (2001) 276:3319–3323.
   PubMed Web of Science ®Google Scholar
• BELLAMY W: The role of glutathione 5-transferases in drug resistance. In: Alternative mechanisms of Multidrug Resistance in Cancer. Kellen JA (Ed.), (1996):31–65.
   Google Scholar
• JURONEN E GT, UUSKULA M, POOGA M, MIKELSAAR AV: Purification, characterisation and tissue distribution of human class theta glutathione 5-transferase T1-1. Biochem. Mol. Biol. Int. (1996) 39:21–29.
   PubMedGoogle Scholar
• HAYES JD, STRANGE RC: Glutathione 5-transferase polymorphisms and their biological consequences. Pharmacology (2000) 61:154–166.
   PubMed Web of Science ®Google Scholar
• REBBECK TR: Molecular epidemiology of the human glutathione 5-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prey (1997) 6:733–743.
   PubMed Web of Science ®Google Scholar
• LAN Q, HEX, COSTA DJ et al.: Indoorcoal combustion emissions, GSTM1 and GSTT1 genotypes, and lung cancer risk: a case-control study in Xuan Wei, China. Cancer Epidemiol Biomarkers Prey (2000) 9:605–608.
   PubMedGoogle Scholar
• SCHLADE-BARTUSIAK K, SADIADEK M, KOZLOWSKA J: The influence of GSTM1 and GSTT1 genotypes on the induction of sister chromatid exchanges and chromosome aberrations by 1,2:3,4-diepoxybutane. Mutat. Res. (2000) 465:69–75.
   PubMed Web of Science ®Google Scholar
• SALAMA SA, BDEL-RAHMAN SZ, SIERRA-TORRES CH, HAMADA FA, AU WW: Role of polymorphic GSTM1 and GSTT1 genotypes on NNK-induced genotoxicity. Pharmacogenetics (1999) 9:735–743.
   PubMedGoogle Scholar
• LANDI S: Mammalian class theta GST anddifferential susceptibility to carcinogens: a review. Mutat. Res. (2000) 463:247–283.
   PubMed Web of Science ®Google Scholar
• SARHANIS P, REDMAN C, PERRETT C et al.: Epithelial ovarian cancer: influence of polymorphism at the glutathione 5-transferase GSTM1 and GSTT1 loci on p53 expression. Br I Cancer (1996) 74: 1757-1761.
   Google Scholar
• LALLAS TA, MC CAIN SK, SHAHIN MS, BULLER RE: The glutathione 5-transferase M1 genotype in ovarian cancer. Cancer Epidemiol Biomarkers Prey (2000) 9:587–590.
   PubMed Web of Science ®Google Scholar
• SPURDLE AB, WEBB PM, PURDIE DM,CHEN X, GREEN A, CHENEVIX-TRENCH G: Polymorphisms at the glutathione 5-transferase GSTM1, GSTT1 and GSTP1 loci: risk of ovarian cancer by histological subtype. Carcinogenesis (2001) 22:67–72.
   PubMed Web of Science ®Google Scholar
• ZHONG S, WYLLIE AH, BARNES D, WOLF CR, SPURR NK: Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis (1993) 14: 1821-1824.
   Google Scholar
• HOULSTON RS: Glutathione S-transferase M1 status and lung cancer risk: a meta-analysis. Cancer Epidennol. Biomarkers Prey. (1999) 8:675–682.
   PubMed Web of Science ®Google Scholar
• ALT-OSMAN F, AKANDE O, ANTOUN G, MAO JX, BUOLAMWINI J: Molecular cloning, characterisation, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J. Biol. Chem. (1997) 272:10004–10012.
   Google Scholar
• HARRIES LW, STUBBINS MJ, FORMAN D, HOWARD GC, WOLF CR: Identification of genetic polymorphisms at the glutathione 5-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis (1997) 18:641–644.
   PubMed Web of Science ®Google Scholar
• SWEENEY C, McCLURE GY, FARES MY et al.: Association between survival after treatment for breast cancer and glutathione 5-transferase P1 Ile105Val polymorphism. Cancer Res. (2000) 60:5621–5624.
   PubMedGoogle Scholar
• HOWIE AF, DOUGLAS JG, J. FR, BECKETT GJ: Measurement of glutathione 5-transferase pi isoenzyme in plasma, a possible marker for adenocarcinoma of the lung. Clin. Chem. (1990) 36:453–456.
   Google Scholar
• HIDA T, KUWABARA M, ARIYOSHI Y et al.: Serum glutathione 5-transferase-pi level as a tumor marker for non-small cell lung cancer. Potential predictive value in chemotherapeutic response. Cancer (1994) 73:1377–1382.
   Google Scholar
• HOWIE AF, BELL D, HAYES PC, HAYESJD, BECKETT GJ: Glutathione 5-transferase isoenzymes in human bronchoalveolar lavage: a possible early marker for the detection of lung cancer. Carcinogenesis (1990) 11:295–300.
   PubMed Web of Science ®Google Scholar
• CHEN YK, UN LM: Immunohistochemical demonstration of epithelial glutathione S- transferase isoenzymes in normal, benign, premalignant and malignant human oral mucosa...J. Oral. Pathol. Med. (1995) 24:316–321.
   PubMed Web of Science ®Google Scholar
• ZHANG L, XIAO Y, PRIDDY R: Increase in placental glutathione 5-transferase in human oral epithelial dysplastic lesions and squamous cell carcinomas. ..J. Oral Pathol. Med. (1994) 23:75–79.
   PubMed Web of Science ®Google Scholar
• CHEN YK, UN LM: Evaluation of glutathione 5-transferase activity in human buccal epithelial dysplasias and squamous cell carcinomas. Int. j Ora] Maxillolac. &mg. (1997) 26:205–209.
   PubMed Web of Science ®Google Scholar
• WANG X, PAVELIC ZP, Li Y et al.: Overexpression and amplification of glutathione 5-transferase pi gene in head and neck squamous cell carcinomas. Clin. Cancer Res. (1997) 3:111–114.
   PubMedGoogle Scholar
• BONGERS V, SNOW GB, de VRIES N et al.: Second primary head and neck squamous cell carcinoma predicted by the glutathione 5-transferase expression in healthy tissue in the direct vicinity of the first tumor. Lab. Invest. (1995) 73:503–510.
   Google Scholar
• BENTZ BG, HAINES GK, RADOSEVICH JA: Glutathione 5-transferase pi in squamous cell carcinoma of the head and neck. Laryngoscope (2000) 110: 1642-1647.
   Google Scholar
• HIRAZONO K, SHINOZUKA T, KUROSHIMA Y, ITOH H, KAWAI K: Immunohistochemical expression of glutathione 5-transferase pi (GST-pi) and chemotherapy response in malignant ovarian tumors. ..J. Obstet. CynaecoL (1995) 21:305–312.
   Google Scholar
• GREEN JA, ROBERTSON LJ, CLARK AH: Glutathione 5-transferase expression in benign and malignant ovarian tumours. Br Cancer (1993) 68:235–239.
   Google Scholar
• GERMAIN I, TETU B, BRISSON J, MONDOR M, CHERIAN MG: Markers of chemoresistance in ovarian carcinomas: an immunohistochemical study of 86 cases. Int. J. CynecoL Pathol. (1996) 15:54–62.
   Google Scholar
• KODATE C, FUKUSHI A, NARITA T, KUDO H, SOMA Y, SATO K: Human placental form of glutathione 5-transferase (GST-pi) as a new immunohistochemical marker for human colonic carcinoma. fpn. Cancer Res. (1986) 77:226–229.
   Google Scholar
• CAIRNS J, WIRGHT C, CATTAN AR et al.: Immunohistochemical demonstration of glutathione S-transferases in primary human breast carcinomas. j Pathol. (1992) 166:19–25.
   PubMed Web of Science ®Google Scholar
• SMITH MT, EVANS CG, DOANE-SETZER P, CASTRO VM, TAHIR MK, MANNERVIK B: Denitrosation of 1,3-bis(2-chloroethyl)-1-nitrosourea by class mu glutathione transferases and its role in cellular resistance in rat brain tumor cells. Cancer Res. (1989) 49:2621–2625.
   PubMed Web of Science ®Google Scholar
• CIACCIO PJ, TEW KD, LA CRETA FP:Enzymatic conjugation of chlorambucil with glutathione by human glutathione S- transferases and inhibition by ethacrynic acid. Biochem. Pharmacy]. (1991) 42:1504–1507.
   PubMed Web of Science ®Google Scholar
• BATIST G, TUPULE A, SINHA BK, KATKI AG, MYERS CE, COWAN KH: Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. J. Biol. Chem. (1986) 261:15544–15549.
   PubMed Web of Science ®Google Scholar
• •One of the first reports showing the overexpression of GSTR in a resistant cell line presenting a MDR phenotype.
   Google Scholar
• TEW KD: Glutathione-associated enzymesin anticancer drug resistance. Cancer Res. (1994) 54:4313–4320.
   PubMed Web of Science ®Google Scholar
• WANG YY, TEICHER BA, SHEA TC et al.: Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance. Cancer Res. (1989) 49:6185–6192.
   PubMed Web of Science ®Google Scholar
• FAIRCHILD CR, MOSCOW JA, O'BRIEN EE, COWAN KH: Multidrug resistance in cells transfected with human genes encoding a variant P-glycoprotein and glutathione 5-transferase-pi. Md. PharmacoL (1990) 37:801–809.
   Google Scholar
• DOROSHOW JH, METZ MZ, MATSUMOTO L et al.: Transduction of NTH 3T3 cells with a retrovirus carrying both human MDR1 and glutathione 5-transferase pi produces broad-range multidrug resistance. Cancer Res. (1995) 55:4073–4078.
   PubMed Web of Science ®Google Scholar
• NAKAGAWA K, SAIJO N, TSUCHIDA S et al.: Glutathione-S-transferase pi as a determinant of drug resistance in transfectant cell lines. j Biol. Chem. (1990) 265:4296–4301.
   PubMed Web of Science ®Google Scholar
• O'BRIEN ML, VULEVIC B, FREER S, BOYD J, SHEN H, TEW KD: Glutathione peptidomimetic drug modulator of multidrug resistance- associated protein. PharmacoL Exp. Ther. (1999) 291:1348–1355.
   PubMed Web of Science ®Google Scholar
• GAUDIANO G, KOCH TH, LO BELLO M et al.: Lack of glutathione conjugation to adriamycin in human breast cancer MCF-7/ DOX cells. Inhibition of glutathione 5-transferase p1-1 by glutathione conjugates from anthracyclines. Biochem. Pharmacy]. (2000) 60:1915–1923.
   Google Scholar
• CIACCIO PJ, TEW KD, LA CRETA FP:The spontaneous and glutathione 5-transferase-mediated reaction of chlorambucil with glutathione. Cancer Commun. (1990) 2:279–285.
   PubMed Web of Science ®Google Scholar
• BLACK SM, BEGGS JD, HAYES JD et all:Expression of human glutathione S-transferases in Saccharomyces cerevisiae confers resistance to the anticancer drugs adriamycin and chlorambucil. Biochem. (1990) 268:309–315.
   Google Scholar
• PUCHALSKI RB, FAHL WE: Expression of recombinant glutathione 5-transferase pi, Ya, or Ybl confers resistance to alkylating agents. Proc. Natl. Acad. Sd. USA (1990) 87:2443–2447.
   PubMed Web of Science ®Google Scholar
• GREENBAUM M, LETOURNEAU S, ASSAR H, SCHECHTER RL, BATIST G, COURNOYER D: Retrovirus-mediated gene transfer of rat glutathione 5-transferase Yc confers alkylating drug resistance in NIH 3T3 mouse fibroblasts. Cancer Res. (1994) 54:4442–4447.
   PubMed Web of Science ®Google Scholar
• MORROW CS, SMITHERMAN PK, DIAH SK, SCHNEIDER E, TOWNSEND AJ: Co-ordinated action of glutathione S-transferases (GSTs) and multidrug resistance protein 1 (MRP1) in antineoplastic drug detoxification. Mechanism of GST A1-1- and MRP1-associated resistance to chlorambucil in MCF7 breast carcinoma cells. J. Biol. Chem. (1998) 273:20114–20120.
   Google Scholar
• NISHIMURA T, NEWKIRK K, SESSIONS RB et al.: Immunohistochemical staining for glutathione 5-transferase predicts response to platinum-based chemotherapy in head and neck cancer. Gin Cancer Res. (1996) 2:1859–1865.
   Google Scholar
• SHIGA H, HEATH El, RASMUSSEN AA et al.: Prognostic value of p53, glutathione 5-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer. Clin. Cancer Res. (1999) 5:4097–4104.
   PubMed Web of Science ®Google Scholar
• BOKU N, CHIN K, HOSOKAWA K et al.: Biological markers as a predictor for response and prognosis of unresectable gastric cancer patients treated with 5-fluorouracil and cis-platinum. CBI]. Cancer Res. (1998) 4:1469–1474.
   PubMedGoogle Scholar
• UOZAKI H, HORIUCHI H, ISHIDA T, IIJIMA T, IMAMURA T RM: Overexpression of resistance-related proteins (met allothioneins, glutathione-S-transferase pi, heat shock protein 27, and lung resistance-related protein) in osteosarcoma. Relationship with poor prognosis. Cancer (1997) 79:2336–2344.
   Google Scholar
• KONISHI I, NANBU K, MANDAI M et al.: Tumor response to neoadjuvant chemotherapy correlates with the expression of P-glycoprotein and PCNA but not GST-pi in the tumor cells of cervical carcinoma. Cynecol. Oncol. (1998) 70:365–371.
   PubMed Web of Science ®Google Scholar
• VENERONI S, SILVESTRINI R, COSTA A, SALVATORI E FARANDA A, MOLINARI R: Biological indicators of survival in patients treated by surgery for squamous cell carcinoma of the oral cavity and oropharynx. Oral Oncol. (1997) 33:408–413.
   PubMedGoogle Scholar
• ALPERT LC, SCHECHTER RL, BERRY DA et al.: Relation of glutathione 5-transferase alpha and mu isoforms to response to therapy in human breast cancer. Clin. Cancer Res. (1997) 3:661–667.
   PubMedGoogle Scholar
• TEW KD, BOMBER AM, HOFFMAN SJ: Ethacrynic acid and piriprost as enhancers of cytotoxicity in drug resistant and sensitive cell lines. Cancer Res. (1988) 48:3622–3625.
   PubMed Web of Science ®Google Scholar
• HALL A, ROBSON CN, HICKSON ID, HARRIS AL, PROCTOR SJ, CATTAN AR: Possible role of inhibition of glutathione 5-transferase in the partial reversal of chlorambucil resistance by indomethacin in a Chinese hamster ovary cell line. Cancer Res. (1989) 49:6265–6268.
   PubMed Web of Science ®Google Scholar
• FORD JM, HAIT WN, MATLIN SA, BENZ CC: Modulation of resistance to alkylating agents in cancer cell by gossypol enantiomers. Cancer Lett. (1991) 56:85–94.
   PubMed Web of Science ®Google Scholar
• CLAPPER ML, HOFFMAN SJ, TEW KD: Sensitization of human colon tumor xenografts to L-phenylalanine mustard using ethacrynic acid. J. Cell. Pharmacol. (1990) 1:71–78.
   Google Scholar
• OAKLEY AJ, LO BELLO M, MAZZETTI AE FEDERICI G, PARKER MW: The glutathione conjugate of ethacrynic acid can bind to human pi class glutathione transferase P1-1 in two different modes. FEBS Lett (1997) 419:32–36.
   PubMed Web of Science ®Google Scholar
• MULDER TI PETERS WH, WOBBES T, WITTEMAN BJ, JANSEN JB: Measurement of glutathione 5-transferase P1-1 in plasma: pitfalls and significance of screening and follow-up of patients with gastrointestinal carcinoma. Cancer (1997) 80:873–880.
   PubMedGoogle Scholar
• O'DWYER PJ, LACRETA F, NASH Set al.: Phase I study of thiotepa in combination with the glutathione transferase inhibitor ethacrynic acid. Cancer Res. (1991) 51:6059–6065.
   Google Scholar
• PETRINI M, CONTE A, CARACCIOLO F, SABBATINI A, GRASSI B, RONCA G: Reversing of chlorambucil resistance by ethacrynic acid in a B-CLL patient. Br J. Haematol. (1993) 85:409–410.
   PubMed Web of Science ®Google Scholar
• KHIL MS, KIM SH, PINTO JT, KIM JH: Ethacrynic acid: a novel radiation enhancer in human carcinoma cells. Int. J. Radiat. Oncol. Biol. Phys. (1996) 34:375–380.
   PubMedGoogle Scholar
• SINGH SV, HU X, SRIVASTAVA SK et al.: Mechanism of inhibition of benzo lalpyrene-induced forestomach cancer in mice by dietary curcumin. Carcinogenesis (1998) 19:1357–1360.
   PubMed Web of Science ®Google Scholar
• ADANG AE, BRUSSEE J, VAN DER GEN A, MULDER GJ: The glutathione-binding site in glutathione S-transferases. Investigation of the cysteinyl, glycyl and gamma-glutamyl domains. Biochem. (1990) 269:47–54.
   Google Scholar
• •This paper describes the role of each glutathione amino-acid in the interactions between the G-site of glutathione S-transferases and GSH.
   Google Scholar
• ASKELOF P, GUTHENBERG C, JAKOBSON I, MANNERVIK B: Purification and characterisation of two glutathione 5-aryltransferase activities from rat liver. Biochem. J. (1975) 147:513–522.
   PubMed Web of Science ®Google Scholar
• FLATGAARD JE, BAUER KE, KAUVAR LM: Isozyme specificity of novel glutathione-S-transferase inhibitors. Cancer Chemother. Pharmacol. (1993) 33:63–70.
   PubMed Web of Science ®Google Scholar
• LYTTLE MH, HOCKER MD, HUI HC et al.: Isozyme-specific glutathione-S-transferase inhibitors: design and synthesis. J. Med. Chem. (1994) 37:189–194.
   PubMed Web of Science ®Google Scholar
• ANDERSON ME, POWRIE F, PURI RN, MEISTER A: Glutathione monoethyl ester: preparation, uptake by tissues, and conversion to glutathione. Arch. Biochem. Biophys. (1985) 239:538–548.
   PubMed Web of Science ®Google Scholar
• MORGAN AS, CIACCIO PJ, TEW KD, KAUVAR LM: Isozyme-specific glutathione 5-transferase inhibitors potentiate drug sensitivity in cultured human tumor cell lines. Cancer Chemother. Pharmacol. (1996) 37:363–370.
   PubMed Web of Science ®Google Scholar
• RUSCOE JE, ROSARIO LA, WANG T et al.: Pharmacologic or genetic manipulation of glutathione 5-transferase P1-1 (GSM) influences cell proliferation pathways. J. Pharmacol. Exp. Ther. (2001) 298:339–345.
   PubMed Web of Science ®Google Scholar
• ADLER V, YIN Z, FUCHS SY et al.: Regulation of JNK signalling by GSTp. EMBO J. (1999) 18:1321-1334. esThe first report concerning the function ofGSM as an inhibitor of JNK1 activity and consequently as a regulator of stress kinases pathways independently of its catalytic properties.
   Google Scholar
• WANG T, ARIFOGLU P, RONAI Z, TEW KD: Glutathione S-transferase P1-1 (GSTP1-1 inhibits c-Jun NH2 terminal kinase (JNK1) signalling through interaction with the carboxyl terminus. ..J. Biol. Chem. (2001) 276:20999–21003.
   PubMed Web of Science ®Google Scholar
• YIN Z, IVANOV VN, HABELHAH H, TEW K, RONAI Z: Glutathione S-transferase p elicits protection against H202-induced cell death via co-ordinated regulation of stress kinases. Cancer Res. (2000) 60:4053–4057.
   PubMed Web of Science ®Google Scholar
• OUWERKERK-MAHADEVAN S, van BOOM JH, DREEF-TROMP MC, PLOEMEN JH, MEYER DJ, MULDER GJ: Glutathione analogues as novel inhibitors of rat and human glutathione S-transferase isoenzymes, as well as of glutathione conjugation in isolated rat hepatocytes and in the rat in vivo. Biochem. (1995) 308:283–290.
   Google Scholar
• KELLER C, ALI-OSMAN F: Translational inhibition of messenger RNA of the human pi class glutathione S-transferase by antisense oligodeoxyribonucleotides. Chem. Biol. Interact. (1998) 111–112:307–323.
   Google Scholar
• NIITSU Y, TAKAHASHI Y, BAN N et al.:A proof of glutathione S-transferase-pi-related multidrug resistance by transfer of antisense gene to cancer cells and sense gene to bone marrow stem cell. Chem. Biol. Interact. (1998) 111–112:325–332.
   Google Scholar
• KUGA T, SAKAMAKI S, MATSUNAGA T et al.: Fibronectin fragment-facilitated retroviral transfer of the glutathione- S-transferase pi gene into CD34+ cells to protect them against alkylating agents. Hum. Gene Ther. (1997) 8:1901–1910.
   PubMedGoogle Scholar
• MORGAN AS, SANDERSON PE, BORCH RF et al.: Tumor efficacy and bone marrow-sparing properties of TER286, a cytotoxin activated by glutathione S-transferase. Cancer Res. (1998) 58:2568–2575.
   PubMed Web of Science ®Google Scholar
• O'BRIEN M, KRUH GD, TEW KD: The influence of co-ordinate overexpression of glutathione phase II detoxification gene products on drug resistance. j Pharmacol. Exp. Ther. (2000) 294:480–487.
   PubMed Web of Science ®Google Scholar
• ROSARIO LA, O'BRIEN ML, HENDERSON CJ, WOLF CR, TEW KD: Cellular response to a glutathione S-transferase P1-1 activated prodrug. Pharmacol. (2000) 58:167–174.
   Google Scholar
• ROSEN LS, KADIB L, LAXA B et al.: TLK-286: Phase I dose-escalation trial in patients with advanced malignancies. 11th NCIEORTC-AACR Symposium on New Drugs in Cancer Therapy. Amsterdam, The Netherlands 2000 Conference. GM Cancer Res. (Suppl.).
   Google Scholar
• DAVIS W JR., RONAI Z, TEW KD: Cellular thiols and reactive oxygen species in drug-induced apoptosis. j Pharmacol. Exp. Ther. (2001) 296:1–6.
   PubMed Web of Science ®Google Scholar
• SAITOH M, NISHITOH H, FUJII M et al.: Mammalian thioredoxin is a direct inhibitor of apoptosis signal- regulating kinase (ASK) 1. EMBO (1998) 17:2596–2606.
   PubMed Web of Science ®Google Scholar
• WANG AL, TEW KD: Increased glutathione-S-transferase activity in a cell line with acquired resistance to nitrogen mustards. Cancer Treat Rep. (1985) 69:677–682.
   PubMedGoogle Scholar
• PETRINI M, Di SIMONE D, FAVATI A, MATTII L, VALENTINI E GRASSI B: GST-pi and P-170 co-expression in multiple myeloma. Br j Haematol. (1995) 90:393–397.
   PubMedGoogle Scholar
• KLYS HS, WHILLIS D, HOWARD G, HARRISON DJ: Glutathione S-transferase expression in the human testis and testicular germ cell neoplasia. Br j Cancer (1992) 66:589–593.
   PubMed Web of Science ®Google Scholar
• KANBAGLI O, OZDEMIRLER G, BULUT T, YAMANER S, AYKAC-TOKER G, UYSAL M: Mitochondrial lipid peroxides and antioxidant enzymes in colorectal adenocarcinoma tissues. fpri Cancer Res. (2000) 91:1258–1263.
   PubMed Web of Science ®Google Scholar